Current Challenges in Gastric Cancer Surgery
Published in Elsevier Connect, researchers review recent trends in treating gastric cancer as well as new reconstructive methods improving post-op... Read More
Our Impact
Gastric Cancer Foundation improves the lives of people affected by gastric (stomach) cancer by supporting patient education initiatives and innovative research studies to improve treatments and ultimately, find a cure.
Join Us at Our 9th Annual Event
Join us Friday, November 9th, for this annual celebration of progress and fundraising to support the search for a cure.
Support Research for a Cure
Every contribution to Gastric Cancer Foundation makes a difference. Honor a loved one, make a tribute to someone’s memory, honor a happy occasion by making a meaningful donation.
-
Long-term survival after liver metastasectomy in gastric cancer: Systematic review and meta-analysis of prognostic factors
With the liver a common site for gastric cancer recurrence, researchers in Elsevier Connect identified prognostic factors for using hepatectomy... Read More
Research Links Specific H. Pylori Strain with Stomach Cancer Risk
An interesting study published in PLOS Medicine identifies a specific H. pylori strain associated with gastric cancer risk.
CARsgen Therapeutics and CrownBio complete CAR-T study for gastric cancer
Research in its very early stages uses engineered immune cells (CAR-T) to target gastric cancer tumors.
Eating junk food tied to higher risk of numerous cancers
A new study in PLOS Medicine finds eating unhealthy food is associated with a higher risk of developing cancer, including... Read More
Five Prime Therapeutics Completes Phase 1 Safety Lead-In and Initiates Phase 3, Global Registrational Trial of Bemarituzumab in Front-Line Advanced Gastric and Gastroesophageal Junction Cancers
A new phase 3 trial of Bemarituzumab for patients with advanced gastric cancer is open for enrollment. Curious about clinical... Read More
November is Gastric Cancer Awareness Month
Get ready for November and think about hosting an event or fundraiser. Reach out to family, friends and colleagues and... Read More
CheckMate-032 Study: Efficacy and Safety of Nivolumab and Nivolumab Plus Ipilimumab in Patients With Metastatic Esophagogastric Cancer
Research published in the American Society of Clinical Oncology shows nivolumab and nivolumab plus ipilimumab has durable response and encouraging long-term... Read More
Have Questions About Gastric Cancer?
We’ve partnered with Smart Patients to offer a custom-built, disease-specific forum. This is a safe, warm, and engaging place to... Read More
Clinicopathologic features and outcomes of gastrointestinal stromal tumors arising from the esophagus and gastroesophageal junction
A small study looks into features and outcomes of gastrointestinal stromal tumors arising from the esophagus and gastroesophageal junction. They... Read More
Breakfast is Up!
In our latest nutrition video for gastric cancer patients, board member and “Chef without a Stomach,” Hans Rueffert, prepares “Kaiserchmarrn” using leftover 7-grain... Read More
A Cause for Hope 2018
Important progress in our mission allows us an evening to pause and celebrate as we transform hope into belief. ... Read More-
Adjuvant Chemotherapy or Adjuvant Chemoradiotherapy for Gastric Cancer?—A West Cancer Center Perspective
“If you gave everybody neoadjuvant chemotherapy, is there an added benefit for chemoradiation after surgery?” Watch researchers from West Cancer... Read More 
Dental care before cancer surgery might be good idea
A new study from Japan shows patients undergoing major surgery for cancer may be able to reduce complication risks by... Read More
Association of MUC16 Mutation With Tumor Mutation Load and Outcomes in Patients With Gastric Cancer
Have you heard of tumor mutation burdens? Recently published in JAMA, researchers discovered gastric cancer tissue samples with a MUC16... Read More
Maintenance use of non-steroidal anti-inflammatory drugs and risk of gastrointestinal cancer in a nationwide population-based cohort study in Sweden
A new study via BMJ finds long-term use of low-dose aspirin and other non-selective non-steroidal anti-inflammatory drugs (NSAIDs) was associated... Read More-
Prognostic Indicators in Stage IV Surgically Treated Gastric Cancer Patients: A Retrospective Multi-Institutional Study
A new study in Digestive Surgery investigates the short and long-term outcomes of stage 4 gastric cancer patients who are... Read More 
Endoscopic predictive factors associated with local recurrence after gastric endoscopic submucosal dissection
Scientists via Taylor & Francis find that while rates of local recurrence after endoscopic submucosal dissection (ESD) of gastric lesions... Read More
Prognostic differences in 8th edition TNM staging of esophagogastric adenocarcinoma after neoadjuvant treatment
Researchers evaluate prognostic differences in esophagogastric cancer stages after patients receive neoadjuvant treatment.
Identifying stomach cancer risk
New research finds people with a potentially precancerous condition are at a higher risk of developing gastric cancer if samples... Read More
Monthly Newsletter
We’ll deliver our monthly newsletter to your Inbox with Foundation updates, news about cutting edge research and trends in the field, and how to make a difference.